Skip to main content

THOMPSON INVESTMENT MANAGEMENT, INC.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1277279 MADISON, WI

Position in NBIX

as of Jun 30, 2026 · filed Jul 13, 2026
Position Value
$1,644,107
+$358,984 QoQ
Shares Held
9,755
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#12
of 51 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

THOMPSON INVESTMENT MANAGEMENT, INC. holds $19,729,477 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (8.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
9,755 $1,644,107

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,644,107 9,755
2026-03-31 $1,285,123 9,755
2025-12-31 $1,383,551 9,755
2025-09-30 $1,369,406 9,755
2025-06-30 $1,226,105 9,755
2025-03-31 $1,078,903 9,755
2024-12-31 $1,205,295 8,830
2024-09-30 $1,123,395 9,750
2024-06-30 $1,087,593 7,900
2024-03-31 $1,051,640 7,625
2023-12-31 $1,014,552 7,700
2023-09-30 $930,937 8,275
2023-06-30 $811,451 8,605
2023-03-31 $833,040 8,230
2022-12-31 $776,957 6,505
2022-09-30 $690,896 6,505
2022-06-30 $760,831 7,805
2022-03-31 $731,718 7,805
2021-12-31 $622,166 7,305
2021-09-30 $664,656 6,930
2021-06-30 $674,427 6,930
2021-03-31 $430,817 4,430
2020-12-31 $424,615 4,430
2020-09-30 $358,676 3,730
2020-06-30 $414,800 3,400